3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
17
Gastrointestinal Stromal Tumors
10
Neoplasms
5
Neoplasm Metastasis
4
Multiple Myeloma
4
Kidney Neoplasms
4
Urologic Neoplasms
2
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Meningioma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Kidney Diseases
2
Gastrointestinal Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rectal Neoplasms
1
Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Interventions
Temozolomide
3
Cyclophosphamide
3
fludarabine phosphate
2
Vincristine
2
PM 01183
2
Irinotecan
2
Ifosfamide
2
Etoposide
2
Doxorubicin
2
thymoglobulin
1
temsirolimus
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
fludarabine
1
Zoledronic Acid
1
Vinorelbine
1
Thiotepa
1
Tacrolimus
1
Surgical Procedures, Operative
1
Stem Cell Transplantation
1
Sorafenib
1
Ramucirumab
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Proton Therapy
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Desmoplastic Small Round Cell Tumor
×
Sunitinib
×
1 year
×
Clear all
No trials found.